Recently there have been contradictory reports about B-cell effects on HCC outcome.[9–16] Especially tumor infiltration by atypical memory B cells, that are CD20+IgD-IgG+CD27-CD38- were significantly associated with improved overall and recurrence-free survival of HCC patients [9]. Here, CD38 is linked to hepatocellular carcinoma.